Cargando…
Comparison of Silicate-Substituted Calcium Phosphate (Actifuse) with Recombinant Human Bone Morphogenetic Protein-2 (Infuse) in Posterolateral Instrumented Lumbar Fusion
Study Design Randomized controlled trial. Objective The aim of this study was to assess the efficacy of the bone grafting substitute silicate-substituted calcium phosphate (SiCaP) compared with recombinant human bone morphogenetic protein 2 (rhBMP-2) and to evaluate the clinical outcomes over a peri...
Autores principales: | Licina, Paul, Coughlan, Marc, Johnston, Emma, Pearcy, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671893/ https://www.ncbi.nlm.nih.gov/pubmed/26682097 http://dx.doi.org/10.1055/s-0035-1566230 |
Ejemplares similares
-
Recombinant human Bone Morphogenetic Protein-2 (rhBMP-2) in posterolateral lumbar spine fusion: complications in the elderly
por: Hoffmann, Martin F, et al.
Publicado: (2013) -
Safety and Efficacy of Recombinant Human Bone Morphogenetic Protein-2 in Multilevel Posterolateral Lumbar Fusion in a Prospective, Randomized, Controlled Trial
por: Choi, Ho Yong, et al.
Publicado: (2022) -
Recombinant Human Bone Morphogenetic Protein-2 in Posterolateral Spinal Fusion: What's the Right Dose?
por: Hoffmann, Martin Franz, et al.
Publicado: (2016) -
The effect of particle size on the osteointegration of injectable silicate-substituted calcium phosphate bone substitute materials
por: Coathup, Melanie J, et al.
Publicado: (2013) -
Rapid hydrothermal flow synthesis and characterisation of carbonate- and silicate-substituted calcium phosphates
por: Chaudhry, Aqif A, et al.
Publicado: (2013)